Curevac Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Curevac Contact Number

Contact Email [email protected]curevac.com Phone Number +49707198830 CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

Contact US: https://www.crunchbase.com/organization/curevac

Where is curevac headquarters?

Headquarters of CureVac in Tübingen CureVac N.V. is a German biopharmaceutical company, legally domiciled in the Netherlands and headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases.

Who is curevac and what do they do?

For more guidance, see Wikipedia:Translation. CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases.

When did curevac enter into research agreement with harvard?

CureVac Enters into an Exclusive Sponsored Research Agreement for Discovery Research in mRNA-based Eye Therapy Candidates with the Schepens Eye Research Institute, Harvard Medical School and the Massachusetts Eye and Ear Infirmary. April 16, 2019.

Company

39 People Used

See More ››

CureVac

CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung and Hans-Georg Rammensee.CureVac had approximately 240 employees in …

View Contact ››

COVID-19

138 People Used

See More ››

Enhanced version of CureVac’s COVID 19 vaccine could help

The challenges faced in COVID-19 vaccine development. Since the COVID-19 outbreak first began in late December 2019, unprecedented efforts to …

View Contact ››

Zimmer

72 People Used

See More ››

CureVac Covid Vaccine Could Bring Hope to the Unvaccinated

The German company CureVac hopes its RNA vaccine will rival those made by Moderna and Pfizer-BioNTech. It could be ready next month. By Carl Zimmer In …

View Contact ››

Vaccine

59 People Used

See More ››

CureVac COVID 19 vaccine

The CureVac COVID-19 vaccine is a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). As of April 2021 it is currently in Phase III clinical trials. The manufacturer markets the vaccine under the name CVnCoV.

View Contact ››

CureVac

71 People Used

See More ››

CureVac mRNA vaccine can be stored at normal fridge

But CureVac can reportedly be stored at ordinary fridge temperatures, meaning a less expensive investment for some of those places. EU and UK signed contracts with CureVac The European Commission has an advanced purchasing agreement with CureVac, for an initial 225 million doses, with the option to buy a further 180 million.

View Contact ››

CureVac

153 People Used

See More ››

CureVac COVID 19 vaccine explainer: Everything you need to

CureVac, a Germany-based pharmaceutical company, has been developing its mRNA-based vaccine candidate against COVID-19. Less than a year after the emergence of the novel coronavirus, the first

View Contact ››

Germany''s

79 People Used

See More ››

CureVac says mass vaccine rollout thrown into doubt by U.S

Germany''s CureVac, which is gearing up to publish results of a key COVID-19 vaccine trial, said U.S. export restrictions on key materials are making it impossible to predict its short-term supply ramp-up in Europe. "Due to the Defense Production Act we are not getting certain goods out of the USA," CureVac Chief Executive Franz-Werner Haas told weekly Der Spiegel.

View Contact ››

Regulators

101 People Used

See More ››

2 Reasons This COVID Vaccine Latecomer Could Gain Major

It has the ability to produce a great number of doses. In fact, CureVac already is manufacturing its vaccine so that it will be ready to meet demand if European regulators give it …

View Contact ››

Contact

37 People Used

See More ››

Contact Transportation Security Administration

Contact Customer Service. How can we help you? Passenger Support. Request assistance with security screening. Claims. Submit a claim for lost/damaged items or personal injury. Lost and Found. Locate items left at a security checkpoint. Media. Contact public affairs. Identification.

View Contact ››

Quarter

74 People Used

See More ››

CureVac hopes to win regulatory approval for its Covid

We use cookies for a number of reasons CureVac announced a loss of €57.3m in the most recent quarter and a €129.8m loss in earnings before taxes in the year ending December 31 2020

View Contact ››

Company

61 People Used

See More ››

CureVac NV

Company profile page for CureVac NV including stock price, company news, press releases, executives, board members, and contact information

View Contact ››

Summary

58 People Used

See More ››

CureVac N.V. (CVAC) Company Profile & Facts

See the company profile for CureVac N.V. (CVAC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

View Contact ››

Learn

44 People Used

See More ››

Facebook Help Center

Learn how to use Facebook, fix a problem, and get answers to your questions.

View Contact ››

Please leave your comments here:

Popular Brands

Cnooc
Cerner
Csi
Cibc